Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17082.12 -98.06 NIFTY 5078.65 -24.90
 

Natco Pharma Nine Months, Natco Pharma Financial Statement & Accounts

Natco Pharma

BSE: 524816  |  NSE: NATCOPHARM  |  ISIN: INE987B01018  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Nine Months of Natco Pharma

------------------- in Rs. Cr. -------------------
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
Sales Turnover 122.98 122.41 139.57 171.09 192.55
Other Income 11.18 24.09 23.81 13.25 12.16
Total Income 134.16 146.50 163.38 184.34 204.71
Total Expenses 103.18 116.05 120.77 139.66 153.63
Operating Profit 19.80 6.36 18.80 31.43 38.92
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- -- 1.65 3.96
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit 30.98 30.45 42.61 44.68 51.08
Interest 10.15 6.16 5.28 7.03 10.45
PBDT 20.83 24.29 37.33 39.30 44.59
Depreciation 4.14 5.00 5.84 6.67 8.55
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT 16.69 19.29 31.49 32.63 36.04
Tax -- 0.12 4.97 4.79 5.88
Net Profit 16.69 19.17 26.52 27.84 30.16
Prior Years Income/Expenses -- -- -- -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share 7.14 7.11 9.76 9.96 10.76
Book Value -- -- -- -- --
Equity 23.38 26.97 27.17 27.94 28.04
Reserves -- -- -- -- --
Face Value 10.00 10.00 10.00 10.00 10.00
Source : Religare Technova
Explore Natco Pharma connections